Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Venous Thrombosis

  Free Subscription


25.06.2018

1 Am J Hematol
4 J Vasc Surg Venous Lymphat Disord


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. STREIFF MB, Milentijevic D, McCrae K, Yannicelli D, et al
    An Answer to "Anticoagulant treatment of cancer-associated venous thromboembolism: Interpreting real-world data with caution" by Mette Sogaard and Peter Bronnum Nielsen.
    Am J Hematol. 2018 Jun 15. doi: 10.1002/ajh.25165.
    PubMed     Text format    


    J Vasc Surg Venous Lymphat Disord

  2. DIAZ QUINTERO L, Salazar Adum JP, Golemi I, Fuentes HE, et al
    Regarding "Risk factors for presence and severity of pulmonary embolism in patients with deep venous thrombosis".
    J Vasc Surg Venous Lymphat Disord. 2018;6:559-560.
    PubMed     Text format    

  3. AVGERINOS ED, Saadeddin Z, Abou Ali AN, Fish L, et al
    A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism.
    J Vasc Surg Venous Lymphat Disord. 2018;6:530-540.
    PubMed     Text format     Abstract available

  4. REIS J 3RD, Alomari AI, Trenor CC 3rd, Adams DM, et al
    Pulmonary thromboembolic events in patients with congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and spinal/skeletal abnormalities and Klippel-Trenaunay syndrome.
    J Vasc Surg Venous Lymphat Disord. 2018;6:511-516.
    PubMed     Text format     Abstract available

  5. JIN S, Sun Z, Li X, Jian T, et al
    May-Thurner syndrome and the risk of pulmonary embolism in patients with acute deep venous thrombosis.
    J Vasc Surg Venous Lymphat Disord. 2018;6:433-440.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Venous Thrombosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: